Table 3. Karyotype of human-derived brain stem cell cultures.
Patient | Sex | Age | Source | P | Karyotype Early | P | Karyotype | Late |
H0938 | F | 40 | SVZ | 4 | 25/25 Normal | 10 | 5/16 | Normal |
H0867 | F | 22 | SVZ+HPC | 8 | 20/20 Normal | 13 | 23/23 | Normal |
H0949 | M | 41 | HPC | 4 | 7/9 Normal | 11 | 25/25 | Normal |
H0980 | F | 53 | HPC | 3 | 22/22 Normal | 915 | 10/252/19 | NormalNormal |
H1004 | M | 38 | HPC | 4 | 21/25 Normal | 1115 | 20/2522/22 | NormalNormal |
H1004 | M | 38 | SVZ | 3 | 25/25 Normal | 101415 | 24/2411/1118/18 | NormalNormalNormal |
H0991 | F | WM | 3 | 15/24 Normal | ||||
H0991 | F | GM | 3 | 21/24 Normal | ||||
H0995 | F | HPC | 2 | 24/24 Normal |
Karyotype of human-derived brain stem cell cultures. Ratios are for number of normal cells (not taking into account loss of Y chromosome) out of total number of cells examined.